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Abstract 61 
Background: The Tpeak – Tend interval, an electrocardiographic marker reflecting transmural 62 
dispersion of repolarization, has been used to predict ventricular tachycardia/fibrillation (VT/VF) 63 
and sudden cardiac death (SCD) in different clinical settings.  64 
Objective: This systematic review and meta-analysis evaluated the significance of Tpeak – Tend 65 
interval in predicting arrhythmic and/or mortality endpoints.  66 
Methods: PubMed, Embase, Cochrane Library and CINAHL Plus databases were searched 67 
through 30th November 2016. 68 
Results: Of the 854 studies identified initially, 33 observational studies involving 155856 69 
patients were included in our meta-analysis. Tpeak – Tend interval prolongation (mean cut-off: 70 
103.3 ± 17.4 ms) was a significant predictor of the arrhythmic or mortality outcomes (odds ratio 71 
(OR): 1.14, 95% CI: 1.11 to 1.17, p < 0.001). When different end-points were analyzed, the ORs 72 
are as follows: VT/VF (1.10, 95% CI: 1.06 to 1.13, p < 0.0001), SCD (1.27, 95% CI 1.17 to 1.39, 73 
p < 0.0001), cardiovascular death (1.40, 95% CI 1.19 to 1.64, p < 0.0001), and all-cause 74 
mortality (4.56, 95% CI 0.62 to 33.68, p < 0.0001). Subgroup analysis for each disease revealed 75 
that the risk of VT/VF or death was highest for Brugada syndrome (OR: 5.68, 95% CI: 1.57 to 76 
20.53, p < 0.01), followed by hypertension (OR: 1.52, 95% CI: 1.26 to 1.85, p < .0001), heart 77 
failure (OR: 1.07, 95% CI: 1.04 to 1.11, p < .0001) and ischemic heart disease (OR: 1.06, 95% 78 
CI: 1.02 to 1.10, p = 0.001). In the general population, a prolonged Tpeak – Tend interval also 79 
predicted arrhythmic or mortality outcomes (OR: 1.59, 95% CI: 1.21 to 2.09, p < 0.001). 80 
Conclusion: The Tpeak – Tend interval is useful risk stratification tool in different diseases and in 81 
the general population. 82 
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 83 
Introduction 84 
Ventricular arrhythmias can take the form of monomorphic or polymorphic ventricular 85 
tachycardia (VT) or ventricular fibrillation (VF). Both are life-threatening, potentially 86 
culminating in sudden cardiac death (SCD). SCD is a major health problem with a devastating 87 
impact on both economic and social issues. The prevalence of SCD is high with up to 60,000 88 
deaths in the U.K. 1, 200,000 deaths in the U.S. 2 and 4 to 5 million deaths worldwide 3, annually. 89 
Reliable stratification markers are therefore of paramount importance in identifying high risk 90 
patients for SCD. Several electrocardiographic (ECG) markers related to increased risk of 91 
arrhythmias and SCD have been proposed 4-6. Traditional ECG markers of ventricular 92 
repolarization including the corrected QT (QTc) interval 
7 and QT dispersion (QTD) 
8 have been 93 
used for risk stratification in various clinical settings. Relatively new ECG markers of ventricular 94 
repolarization, such as the interval from the peak to the end of the T wave (Tpeak – Tend) 9, and the 95 
(Tpeak – Tend)/QT ratio 10, have been recently proposed to predict ventricular arrhythmic events 96 
and SCD 11. These ECG markers have been validated in congenital ion channelopathies such as 97 
Long QT and Brugada syndromes 12-14, myocardial infarction 15, cardiomyopathies 16 and other 98 
diseases such as pulmonary embolism, hypertension and Chagas disease 17, 18. However, data are 99 
controversial regarding the predictive value of these ECG markers 19-23. The present systematic 100 
review and meta-analysis of the current literature aimed to investigate the prognostic significance 101 
of Tpeak – Tend interval with respect to arrhythmic and mortality outcomes. 102 
 103 
Method 104 
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Search strategy, inclusion and exclusion criteria 105 
The meta-analysis was performed according to the Preferred Reporting Items for 106 
Systematic Reviews and Meta-Analyses statement 24. MEDLINE, Embase, Cochrane library and 107 
CINAHL Plus were searched for studies that investigated the relationship between Tpeak – Tend 108 
interval with arrhythmic or mortality endpoints using the following terms: [“Tpeak – Tend” OR 109 
“Tpeak–Tend” OR “Tp - Te” OR “Tp-Te” OR “Tpeak-end” OR “Tp-e” OR "T(peak)-T(end)" 110 
OR "T wave peak-to-end" OR "T peak-T end" OR "TPEc" OR "T-peak to T-end" OR "Tpeak-to-111 
tend"]. The search period was from the beginning of the databases (1965 for PubMed, 1910 for 112 
Embase, 1996 for Cochrane Library, 1937 for CINAHL Plus) through to 30th November 2016, 113 
with no language restrictions. The following inclusion criteria were applied: i) the design was a 114 
case-control, prospective or retrospective observational study in humans, ii) Tpeak – Tend interval 115 
durations were determined; iii) endpoint events [appropriate implantable cardioverter-116 
defibrillator therapy (ICD), ventricular tachycardia/fibrillation (VT/VF), sudden cardiac death 117 
(SCD), cardiovascular death (CVD) or all-cause mortality were reported and iv) odds ratios 118 
(ORs) or hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) or data 119 
necessary to calculate these were described.  120 
The quality assessment of these studies included in our meta-analysis was performed 121 
using the Newcastle–Ottawa Quality Assessment Scale (NOS) 25. The point score system 122 
evaluated the categories of study participant selection, comparability of the results, and quality of 123 
the outcomes. The following characteristics were assessed: a) representativeness of the exposed 124 
cohort; b) selection of the non-exposed cohort; c) ascertainment of exposure; d) demonstration 125 
that outcome of interest was not present at the start of study; e) comparability of cohorts on the 126 
basis of the design or analysis; f) assessment of outcomes; g) follow-up period sufficiently long 127 
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for outcomes to occur; and h) adequacy of follow-up of cohorts. This scale varied from zero to 128 
nine stars, which indicated that studies were graded as poor quality if they met <5 criteria, fair if 129 
they met 5 to 7 criteria, and good if they met >8 criteria. The details of the NOS quality 130 
assessment are shown in Supplementary Tables 1 and 2. 131 
 132 
Data extraction and statistical analysis  133 
Data from the different studies were entered in pre-specified spreadsheet in Microsoft 134 
Excel. All potentially relevant reports were retrieved as complete manuscripts and assessed for 135 
compliance with the inclusion criteria. In this meta-analysis, the extracted data elements 136 
consisted of: i) publication details: last name of first author, publication year and locations; ii) 137 
study design; iii) follow-up duration; iv) definition of Tpeak - Tend interval; v) lead(s) where the 138 
Tpeak - Tend interval was measured; vi) endpoint(s); vii) the quality score; and viii) the 139 
characteristics of the population including sample size, gender, age and number of subjects. 140 
Meta-analyses of observational studies are challenging due to differences in study designs and 141 
inherent biases. This systematic review was conducted in accordance to PRISMA statement 26 142 
and registered with PROSPERO (Review number 52916). Two reviewers (GT and MG) 143 
independently reviewed each included study and disagreements were resolved by adjudication 144 
with input from a third reviewer (TL).  145 
The endpoints of the study were the occurrences of ventricular arrhythmias (VT/VF), 146 
SCD, cardiovascular death or all-cause mortality. The definition of these endpoints used in the 147 
different studies were analyzed. If more than one mortality endpoint was described, then SCD 148 
was preferentially used for analysis, followed by cardiovascular death and all-cause mortality. 149 
Multivariate adjusted odds ratios (OR) or hazard ratios (HR) with 95% confidence interval (CI) 150 
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were extracted and analyzed for each study. When values from multivariate analysis were not 151 
available, those from univariate analysis were used. When the latter were not provided, raw data 152 
were used to calculate unadjusted risk estimates where possible. Where arrhythmic or mortality 153 
outcomes were determined but ORs or HRs were not reported, we contacted the corresponding 154 
authors of the studies. HR value in multivariate Cox proportional hazards model was equated as 155 
OR. The pooled adjusted risk estimates from each study as the OR values with 95% CI were 156 
presented.  157 
The heterogeneity between studies was determined using Cochran's Q, the weighted sum 158 
of squared differences between individual study effects and the pooled effect across studies, and 159 
the I2 statistic from the standard chi-square test, which describes the percentage of the variability 160 
in effect estimates resulting from heterogeneity, rather than sampling error. I2 > 50% was 161 
considered to reflect significant statistical heterogeneity. A fixed effects model was used if I2 < 162 
50%, otherwise the random-effects model using the inverse variance heterogeneity method was 163 
used. To locate the origin of the heterogeneity, sensitivity analysis excluding one study at a time, 164 
and subgroup analyses based on different disease conditions and different endpoints were 165 
performed. Funnel plots, Begg and Mazumdar rank correlation test and Egger’s test were used to 166 
assess for possible publication bias. 167 
 168 
Results 169 
A flow diagram detailing the above search terms with inclusion and exclusion criteria is 170 
depicted in Figure 1. A total of 401, 310, 27 and 122 entries were retrieved from PubMed, 171 
Embase, Cochrane Library and CINAHL Plus, respectively. Comparing with the entries 172 
extracted from the PubMed search, 143, 23 and 116 duplicate entries from the Embase, Cochrane 173 
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library and CINAHL Plus searches were found and removed. This yielded 854 publications and 174 
further assessment demonstrated that 30 met the inclusion criteria 5, 10, 15, 22, 27-50. Three groups 175 
provided their data on odds ratio (OR) or hazard ratio (HR), and these studies were also included. 176 
Thus, in the final meta-analysis, 33 studies were included.  177 
A total of 155856 patients were included. Three studies examined the risk in different 178 
patient populations (normotensive and hypertensive; dilated cardiomyopathy and ischemic 179 
cardiomyopathy; normal intraventricular conduction and intraventricular conduction delay). The 180 
Tpeak – Tend interval was examined in the following clinical settings: heart failure in eight studies 181 
27, 31, 35, 38, 40, 41, 45, 48, ischemic heart disease in eight studies 15, 22, 36, 39, 40, 43, 49, 53, Brugada 182 
syndrome in six studies 5, 10, 29, 34, 44, 50, hypertension in two studies 30, 51, pulmonary embolism in 183 
one study 33, Chagas disease in one study 37, intraventricular conduction delay in one study 42, 184 
dilated cardiomyopathy in one study 40 and ischemic cardiomyopathy in one study 40. Five 185 
studies addressed the prognostic significance of Tpeak – Tend interval in the general population 28, 186 
30, 32, 42, 46. The baseline characteristics of these studies are listed in Table 1. Fifteen were 187 
prospective studies and 14 were retrospective studies. The mean follow-up duration was 42 ± 48 188 
months.  189 
In the 33 studies, the total number of patients was 155856 (mean: 4329; range from 23 to 190 
138404). The mean age was 62 ± 11 years old). The subjects were predominantly male (69%). 191 
The mean cut-off point for Tpeak – Tend interval was 103.3 ± 17.4 ms (range between 77.4 and 192 
146.4 ms). All studies consistently reported a positive association between increased Tpeak – Tend 193 
interval and increased risk of VT/VF or SCD (17 using multivariate analysis and 16 using 194 
univariate analysis). The pooled meta-analysis demonstrated that prolonged Tpeak – Tend interval 195 
is associated with 1.14 times higher risk of VT/VF or SCD (95% CI: 1.11 to 1.17, p < 0.0001; 196 
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Figure 2). The Cochran’s Q value was greater than the degrees of freedom (432 vs. 34), 197 
suggesting the true effect size was different among the various studies. Moreover, I2 took a value 198 
of 92%, suggesting significant heterogeneity was present. Funnel plot plotting standard errors or 199 
precision against the logarithms of the odds ratio are shown in Figures 3 and 4, respectively. 200 
Begg and Mazumdar rank correlation suggested no significant publication bias (Kendal’s Tau 201 
value 0.15, p > 0.05). Egger’s test demonstrated significant asymmetry (intercept 3.5, t-value 8.1; 202 
P < 0.0001) 52. When HR and OR were analyzed separately, the data were as follows: HR = 1.12 203 
(95% CI: 1.09 to 1.16, p < 0.0001; Figure A1); OR = 1.23 (95% CI: 1.14 to 1.32, p < 0.0001; 204 
Figure A2). 205 
To locate the origin of the heterogeneity, sensitivity analysis excluding one study at a 206 
time, and subgroup analyses based on different disease conditions and endpoints were 207 
performed. Sensitivity analysis by the leave-one-out method did not affect the overall odds ratio 208 
when each study was removed. VT/VF and different mortality measures were subsequently 209 
analyzed as different end-points. For spontaneous and inducible VT/VF, the OR was 1.10 (95% 210 
CI: 1.06 to 1.13, p < 0.0001) (Figure A3). Exclusion of three studies reporting inducible VT/VF 211 
did not significantly alter the pooled OR (1.09, 95% CI: 1.06 to 1.13; Figure A4). For mortality 212 
endpoints, the ORs were: SCD (1.27, 95% CI 1.17 to 1.39, p < 0.0001; Figure A5), 213 
cardiovascular death (1.40, 95% CI 1.19 to 1.64, p < 0.0001; Figure A6), and all-cause mortality 214 
(4.56, 95% CI 0.62 to 33.68, p < 0.0001; Figure A7). Subgroup analyses based on diagnosis were 215 
subsequently performed.  216 
 217 
Heart failure 218 
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For heart failure, eight studies 27, 31, 35, 38, 40, 41, 45, 48 consisting of 1912 patients (range from 219 
84 to 572) with a mean age of 64 ± 13 years (72% males) were included. The mean follow-up 220 
period was 21 ± 14 months. The mean cut-off point for Tpeak – Tend interval was 106.3 ± 8.4 ms. 221 
All eight groups consistently reported a positive association between increased Tpeak – Tend 222 
interval and increased risk of VT/VF or SCD (7 using multivariate analysis and 1 using 223 
univariate analysis). The pooled meta-analysis demonstrated that prolonged Tpeak – Tend interval 224 
was associated with approximately 1.07 times the risk of these endpoints (95% CI: 1.04 to 1.11, 225 
p < 0.0001; Figure A8). The Cochran’s Q value was greater than the degrees of freedom (56 vs. 226 
6), which would suggest different true effect size among different studies. I2 took a value of 227 
88%, suggesting most of the observed variance reflects heterogeneity between studies.  228 
 229 
Ischemic heart disease 230 
For ischemic heart disease, data from eight studies involving 3402 subjects were included 231 
in the sub-group analysis 15, 22, 36, 39, 40, 43, 49, 53. The mean age was 63 ± 12 years old (77% males). 232 
The mean follow-up period was 18 ± 12 months. The mean cut-off point for Tpeak – Tend interval 233 
was 109.6 ± 20.4 ms. All eight studies consistently reported a positive association between 234 
increased Tpeak – Tend interval and increased risk of VT/VF or SCD (three studies using 235 
multivariate analysis and five studies using univariate analysis). The pooled meta-analysis 236 
demonstrated that prolonged Tpeak – Tend interval is associated with approximately 1.06 times the 237 
risk of these endpoints (95% CI: 1.02 to 1.10; p < 0.001) (Fig. A9). The Cochran’s Q value was 238 
greater than the degrees of freedom (51 vs. 6), indicating the true effect size were different 239 
among different studies. A I2 value of 89.6% suggested that most of the observed variances 240 
reflect differences in true effect sizes. 241 
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 242 
Brugada syndrome 243 
For Brugada syndrome, six studies involving 583 subjects were included (range from 23 244 
to 325) 5, 10, 29, 34, 44, 50. The mean age was 46 ± 11 years old and 80% of subjects were male. The 245 
mean follow-up period was 50 ± 8 months. The mean cut-off point for Tpeak – Tend interval was 246 
95.8 ± 16.3 ms. All six studies consistently reported a positive association between increased 247 
Tpeak – Tend interval and increased risk of VT/VF or SCD (2 using multivariate analysis and 4 248 
using univariate analysis). The pooled meta-analysis demonstrated that prolonged Tpeak – Tend 249 
interval is associated with approximately 5.68 times the risk of these endpoints (95% CI: 1.57 to 250 
20.53, p < 0.001; Fig. A10). The Cochran’s Q value was greater than the degrees of freedom (35 251 
vs. 5), indicating that differing true effect sizes among the different studies. An I2 of 86% 252 
suggests high heterogeneity. 253 
 254 
Hypertension 255 
For hypertension, two studies involving 881 subjects were included (range from 57 to 256 
824) 30, 51. The mean age was 51 ± 11 years old and 55% of subjects were male. The mean 257 
follow-up period was 192 months. The mean cut-off point for Tpeak – Tend interval was 96.7 ± 258 
36.3 ms. Both studies consistently reported a positive association between increased Tpeak – Tend 259 
interval and increased risk of VT/VF or SCD in multivariate analysis. The pooled meta-analysis 260 
demonstrated that prolonged Tpeak – Tend interval is associated with approximately 1.52 times the 261 
risk of these endpoints (95% CI: 1.26 to 1.85, p < 0.01; Fig. A10). The Cochran’s Q value was 262 
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greater than the degrees of freedom (1.1 vs. 1), indicating that differing true effect sizes among 263 
the different studies. An I2 of 6% suggests a low heterogeneity. 264 
 265 
General population 266 
For the general population, five studies involving 148215 subjects (mean age 62 ± 11 267 
years old, 43% males) were included (ranges from 65 to 138404) 28, 30, 32, 42, 46. The mean follow-268 
up period was 111 ± 55 months. The mean cut-off point for Tpeak – Tend interval was 99.8 ± 27.6 269 
ms. All five studies consistently reported a positive association between increased Tpeak – Tend 270 
interval and increased risk of VT/VF or SCD (2 using multivariate analysis and 3 using 271 
univariate analysis). The pooled meta-analysis demonstrated that prolonged Tpeak – Tend interval 272 
is associated with approximately 1.6 times higher risk of reaching these endpoints (95% CI: 1.2 273 
to 2.1, p < 0.0001; Figure A12). The Cochran’s Q value was less than the degrees of freedom (25 274 
vs. 4), indicating that differing true effect sizes among the different studies. An I2 value of 84.0% 275 
suggests a high heterogeneity among studies. 276 
 277 
Discussion 278 
The main findings of this study are the following: 279 
i. A prolonged Tpeak – Tend is associated with a 1.14 fold increased risk in VT/VF, 280 
SCD, cardiovascular death or all-cause mortality when data from all pathological 281 
conditions were pooled with significant heterogeneity among studies; 282 
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ii. Subgroup analyses demonstrated that the risk of VT/VF and/or SCD in Brugada 283 
syndrome was the highest with a 5.6 fold increase compared to 1.52 in 284 
hypertension, 1.07 in heart failure and 1.06 in ischemic heart disease.  285 
iii. In the general population, a prolonged Tpeak – Tend interval was also predictive of 286 
arrhythmic or mortality outcomes with an OR of 1.59. 287 
The cellular origin of the T-wave has been an area of intense study the previous decades 288 
54-56. The waveform has been attributed to electrophysiological characteristics of ventricular 289 
cardiomyocytes located in the different regions of the myocardial wall, such as epicardium, mid-290 
myocardium (M) and endocardium 57. Tpeak – Tend is defined as the interval between the peak of 291 
the T wave and the end of the T wave, representing the dispersion of repolarization 9. Initially, it 292 
was hypothesized that the Tpeak – Tend interval reflects the transmural dispersion of repolarization 293 
(TDR). Later work found that the end of epicardial repolarization coincided with Tpeak and end of 294 
M-cell repolarization coincided with Tend 
58. Subsequent experiments in pigs demonstrated that 295 
Tpeak coincided with the earliest end of repolarization, whereas Tend coincided with the latest end 296 
of repolarization. In other words, Tpeak – Tend was a measure of global dispersion of 297 
repolarization rather than TDR 9, 59-61. Tpeak – Tend is also lead-dependent as the dispersion of 298 
repolarization varies with different cardiac regions 62. Therefore, for left ventricular diseases, 299 
measurements from lead V5 and for right ventricular diseases such as Brugada syndrome, 300 
measurements from lead V2, have been used for ECG interval analysis. In some studies, Tpeak – 301 
Tend were calculated from mean values of all 12 leads. Although the mechanism of the T wave 302 
generation remains controversial, as to whether it represents global or transmural dispersion of 303 
repolarization, a prolonged Tpeak – Tend interval has been associated with an increased incidence 304 
of ventricular tachyarrhythmias 5, 10, 15, 22, 27-50, 63. Increased spatial dispersion of repolarization 305 
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can produce unidirectional block, which predisposes to circus-type or spiral reentry 60, 64-66. 306 
Moreover, this may reflect loss of the action potential dome in the epicardial region compared to 307 
the endocardial region. This is expected to increase the risk of phase 2 reentry 67, 68. Several ECG 308 
parameters, such as QT interval, QT dispersion and T-wave alternans (TWA) are associated with 309 
Tpeak – Tend. The occurrence of TWA is expected to increase the spatial dispersion of 310 
repolarization. Indeed, microvolt TWAs have been associated with the duration of Tpeak – Tend 4. 311 
The mechanism of TWA generation is multi-factorial but has traditionally been described by the 312 
restitution hypothesis 5. The TWA magnitude is likely a function of the heterogeneity in Ca2+ 313 
alternans which can drive APD alternans. Conversely, a steep spatial gradient of repolarization 314 
can convert spatially concordant alternans to spatially discordant alternans. 315 
The prognostic significance of Tpeak – Tend interval has been investigated in various 316 
clinical settings. A prolonged Tpeak – Tend interval has been associated with increased 317 
arrhythmogenicity in Long QT syndrome (LQTS)1 and LQTS2 at baseline 69. Exercise is known 318 
to trigger ventricular arrhythmias in LQTS1 but not LQTS2. Greater increases in Tpeak – Tend 319 
interval were observed in LQTS1, suggesting that it could be a useful risk marker for 320 
arrhythmogenesis in this LQTS subtype. An accentuation of the Tpeak - Tend interval has been 321 
associated an increased propensity to develop Torsades de Pointes (TdP) in subjects with LQTS1 322 
12. The Tpeak – Tend interval is also increased in Short QT syndrome (12). There are limited data 323 
regarding the utility of Tpeak - Tend interval in Brugada syndrome 
10, 13, 14, 50. A prolonged Tpeak – 324 
Tend interval has been associated with arrhythmic events in Brugada syndrome 
50, which is 325 
consistent with pre-clinical data that TDR is involved in arrhythmogenesis in Brugada syndrome 326 
70-73. Previous studies have underscored the prognostic significance of Tpeak – Tend interval in 327 
subjects with structural heart disease including hypertrophic cardiomyopathy and myocardial 328 
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infarction. The Copenhagen study found an inverted U relationship between Tpeak – Tend interval 329 
and the risk of all-cause and cardiovascular mortality, atrial fibrillation and heart failure 32. 330 
However, the abitily of Tpeak – Tend interval to predict prognosis or arrhythmic events has not 331 
always been successful 19-21, 23. Moreover, shortenings of this interval also predicted worsened 332 
survival rates 74. 333 
As shown in our meta-analysis, a prolonged Tpeak – Tend interval displays the highest 334 
predictive ability for arrhythmic events in Brugada syndrome compared to other clinical 335 
conditions.  336 
In Brugada syndrome, both the depolarization and repolarization hypotheses have been 337 
proposed to explain the abnormal electrophysiological findings 71, 75. This would lend weight 338 
towards abnormal repolarization being a significant contributor to arrhythmic substrate. On the 339 
contrary, in heart failure patients, there is only a small, albeit significant, increase in arrhythmic 340 
risk. This possibly suggests that increased dispersion of repolarization plays a moderated role in 341 
ventricular arrhythmogenesis, and other factors such as abnormal action potential restitution 76 or 342 
conduction abnormalities may be more important 77. 343 
It should be noted that the results are not dramatic. Based on this meta-analysis we would 344 
advocate that a different cut-off value should be considered for each cardiac pathology which 345 
should also be considered alongside other known factors known to associate with cardiac risk 346 
such as such as QT interval, QT dispersion or T wave alternans 78. Increased dispersion of 347 
repolarization, which is reflected by the prolonged Tpeak – Tend intervals, is only one mechanism 348 
by which re-entrant mechanism is generated. Indeed, in Mines’ seminal work on circus-type re-349 
entry, his proposal included three criteria:  the presence of unidirectional conduction block, a 350 
distinct pathway along which the cardiac excitation can propagate, and interruption of the circuit 351 
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will terminate the re-entrant activity 79. Prolonged Tpeak – Tend interval will increase the 352 
likelihood of generating unidirectional conduction block, but other factors, such as slowed 353 
conduction and increased dispersion of conduction are also important but not reflected in the 354 
Tpeak – Tend interval. A recent meta-analysis showed that another measure of repolarization, the 355 
QT interval, predicted mortality 80. The results were more dramatic, reporting a 24% increase in 356 
the risk of SCD with every 50 millisecond increase in the QT interval. 357 
 358 
Cut-off points for different conditions 359 
Of the different study populations, the degree of Tpeak – Tend prolongation for significant 360 
elevations in arrhythmic risk for the general population is the greatest with a cut-off point of 361 
113.6 ms. For some diseased states, the cut-off value is much lower. Thus, for Brugada 362 
syndrome and heart failure, the cut-off values for Tpeak – Tend duration were 95.8 ms and 106.3 363 
ms, respectively. Interestingly, the cut-off for ischemic heart disease patients was not 364 
significantly different form that of the general population, with a value of 109.6 ms. Whilst the 365 
Tpeak – Tend could provide additional information for risk stratification, at the moment it should 366 
not be used on its own in estimating arrhythmia risk. However, it could provide incremental 367 
information regarding risk stratification in more complex patients and when the risk estimation 368 
based on conventional parameters might be difficult to calculate.  369 
 370 
Limitations 371 
This systematic review with meta-analysis has several potential limitations. Firstly, 372 
hazard ratios were equated as odds ratios. It has been suggested that when event rates or 373 
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probabilities are low, hazard ratios and odds ratios can be equated 81. Nonetheless, we have 374 
performed additional analysis by pooling HRs and ORs separately. Secondly, a significant 375 
heterogeneity among studies was noted. Sensitivity analysis removing one study at a time did not 376 
alter the pooled odds ratio. Therefore, in the overall meta-analysis, the heterogeneity is likely 377 
derived from the distinct patient populations with different diseases. Thirdly, publication bias in 378 
meta-analyses is frequently examined by checking for asymmetry in a funnel plot. In our case 379 
there was significant asymmetry, which may suggest some bias. However, it is known that effect 380 
estimates such as odd ratios used in this meta-analysis correlate with standard errors, and can 381 
produce asymmetry in a funnel plot. Fourthly, some studies included in our studies are 382 
retrospective studies, which may have more recall bias. Finally, although the overall number of 383 
patients included in this meta-analysis is large, for certain conditions such as Brugada syndrome 384 
a small number of patients (500 patients) were included potentially affecting or masking the true 385 
effect. Finally, our systematic review only included articles published in PubMed, Embase, 386 
Cochrane and CINAHL. It therefore might have missed articles that were not indexed in these 387 
search engines.  388 
 389 
Tables 390 
Table 1. Characteristics of the 33 studies included in the meta-analysis. 391 
 392 
Appendices 393 
Figure A1. Forest plot demonstrating the hazard ratios for studies examining the relationship 394 
between Tpeak – Tend and arrhythmic or mortality outcomes. 395 
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Figure A2. Forest plot demonstrating the odds ratios for studies examining the relationship 396 
between Tpeak – Tend and arrhythmic or mortality outcomes. 397 
Figure A3. Forest plot demonstrating the odds ratios for studies reporting inducible or 398 
spontaneous VT/VF outcomes. 399 
Figure A4. Forest plot demonstrating the odds ratios for studies reporting spontaneous VT/VF 400 
outcomes. 401 
Figure A5. Forest plot demonstrating the odds ratios for studies reporting sudden cardiac death. 402 
Figure A6. Forest plot demonstrating the odds ratios for studies reporting cardiovascular death. 403 
Figure A7. Forest plot demonstrating the odds ratios for studies reporting all-cause mortality. 404 
Figure A8. Forest plot demonstrating the association between Tpeak – Tend and arrhythmic or 405 
mortality outcomes in patients with heart failure. 406 
Figure A9. Forest plot demonstrating the association between Tpeak – Tend and arrhythmic or 407 
mortality outcomes in patients with ischemic heart disease. 408 
Figure A10. Forest plot demonstrating the association between Tpeak – Tend and arrhythmic or 409 
mortality outcomes in patients with Brugada syndrome. 410 
Figure A11. Forest plot demonstrating the association between Tpeak – Tend and arrhythmic or 411 
mortality outcomes in patients with hypertension. 412 
Figure A12. Forest plot demonstrating the association between Tpeak – Tend and arrhythmic or 413 
mortality events in the general population. 414 
Supplementary Table 1. NOS risk of bias scale for case-control studies. 415 
Supplementary Table 2. NOS risk of bias scale for cohort studies. 416 
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Figure 1. Flow diagram of the study selection process. 658 
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Figure 2. Forest plot demonstrating the association between Tpeak – Tend and arrhythmic or 661 
mortality outcomes in patient populations with different clinical conditions. 662 
663 
28 
 
 664 
Figure 3. Funnel plot of standard errors against logarithms of odds ratios. 665 
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Figure 4. Funnel plot of precision measure against logarithms of odds ratios. 669 
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